The role of growth factors in the activity of pharmacological differentiation agents

Cell Growth and Differentiation

Volumn 13, Issue 6, 2002, Pages 275-283

  Matsui, William H ^a   Gladstone, Douglas E ^a   Vala, Milada S ^a   Barber, James P ^a   Brodsky, Robert A ^a   Smith, B Douglas ^a   Jones, Richard J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; ARYLBUTYRIC ACID DERIVATIVE; BRYOSTATIN 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; HYDROXYUREA; ANTINEOPLASTIC AGENT; LACTONE; LEUKOCYTE ANTIGEN; MACROLIDE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; ACUTE DISEASE; CELL CULTURE; CELL LINEAGE; DRUG COMBINATION; ENZYME ACTIVATION; HEMATOPOIETIC STEM CELL; METABOLISM; MYELOID LEUKEMIA;

ACUTE DISEASE; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; DRUG COMBINATIONS; ENZYME ACTIVATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMAN; HYDROXYUREA; LACTONES; LEUKEMIA, MYELOID; PHENYLBUTYRATES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; HUMANS; MACROLIDES;

EID: 0035989909     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Long-term survival in acute myeloid leukemia: The Eastern Cooperative Oncology Group experience
2. Acute myeloid leukemia
3. A systematic overview of chemotherapy effects in acute myeloid leukaemia
4. Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells
5. Varied differentiation responses of human leukemias to bryostatin 1
6. Bryostatin 1, a unique biologic response modifier: Anti-leukemic activity in vitro
7. Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells
8. The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factors
9. Bryostatin 1 modulates the proliferation and lineage commitment of human myeloid progenitor cells exposed to recombinant interleukin-3 and recombinant granulocyte-macrophage colony-stimulating factor
10. Potentiation of the activity of 1-β-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: Association with enhanced fragmentation of mature DNA
11. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor
12. GM-CSF stimulates proliferation of clonal leukemic bone marrow cells in acute myeloid leukemia (AML) in vitro
13. Cytokine-regulated expression of survivin in myeloid leukemia
14. Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: A randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group
15. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60)
16. Protein kinase C-alpha but not protein kinase C-epsilon is differentially down-regulated by bryostatin 1 and tetradecanoyl phorbol 13-acetate in SH-SY5Y human neuroblastoma cells
17. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts
18. Ubiquitination of protein kinase Cα and degradation by the proteasome
19. Bryostatin 1 (bryol)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors
20. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937)
21. Mitogen-activated protein kinase is involved in the degradation of p53 protein in the bryostatin-1-induced differentiation of the acute promyelocytic leukemia NB4 cell line
22. Up-regulation of p21WAF1 expression in myeloid cells is activated by the protein kinase C pathway
23. Activation of human T lymphocytes by bryostatin
24. Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1
25. Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression
26. Changes in antigen expression on differentiating HL60 cells treated with dimethylsulfoxide, all-trans retinoic acid, α1,25-dihydroxy-vitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate
27. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines
28. M-CSF and 1,25-dihydroxy vitamin D3 synergize with 12-O-tetradecanoylphorbol-13-acetate to induce macrophage differentiation in acute promyelocytic leukemia NB4 cells
29. Interleukin-3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG-01 cells
30. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family
31. Erythroid burst-promoting activity of purified recombinant human GM-CSF and interleukin-3: Studies with anti-GM-CSF and anti-IL-3 sera and studies in serum-free cultures
32. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition
33. Mechanisms of differentiation of U937 leukemic cells induced by GM-CSF and 1,25(OH)2 vitamin D3
34. Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: Structure-function analysis
35. Dynamics of interaction between DNA-specific antitumor agents and serum-contained cytokines in the initiation of ML-1 human myeloblastic leukemia cell differentiation
36. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21CIP1 in leukemic cell (U937) differentiation induced by low concentrations of 1-β-D-arabinofuranosylcytosine
37. Regulation of c-jun mRNA expression by hydroxyurea in human K562 cells during erythroid differentiation
38. Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation
39. Differentiation-related changes in the cell cycle traverse
40. Differentiation-related mechanisms which suppress DNA replication
41. Inhibition of ribonucleoside diphosphate reductase by hydroxyurea
42. Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-β-D-arabinofuranosylcytosine in highly resistant human leukemia cells
43. Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase
44. Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo
45. Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1α-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea
46. 6,2′-O-dibutyryladenosine-3′:5′-cyclic monophosphate on growth, differentiation and gene expression in U937 human monoblastoid cells
47. Granulocyte-macrophage colony-stimulating factor, phorbol ester, and sodium butyrate induce the CD11c integrin gene promoter activity during myeloid cell differentiation
48. Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937)
49. Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1
50. Cell differentiation in acute myeloid leukemia
51. Two-step differentiation of AML-193 leukemic line: Terminal maturation is induced by positive interaction of retinoic acid with granulocyte colony-stimulating factor (CSF) and vitamin D3 with monocyte CSF
52. Primary human acute myeloblastic leukaemia: An analysis of in vitro granulocytic maturation following stimulation with retinoic acid and G-CSF
53. Neopterin release by myeloid leukaemic cells can be synergistically augmented by 1,25-dihydroxyvitamin D3 in combination with γ interferon or granulocyte-macrophage colony stimulating factor
54. Growth factor-mediated terminal differentiation of chronic myeloid leukemia
55. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia
56. Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation
57. BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: A mechanism of resistance to multiple anticancer agents
58. ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block
59. p21Cip1/ WAF1 is important for differentiation and survival of U937 cells
60. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation
61. Induced cell differentiation in cancer therapy
62. Hematopoietic stem cell quiescence maintained by p21cip1/waf1
63. Quiescence of CD34-negative haematopoietic stem cells is mediated by downregulation of cyclin B and no Stat activation
64. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the GO/G1 phase of the cell cycle
65. All-trans-retinoic acid in acute promyelocytic leukemia
66. Differentiation therapy of myelodysplastic syndromes: Fact or fiction?
67. Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor
68. Inhibited apoptosis and drug resistance in acute myeloid leukemia
69. Leukocyte CD11/CD18 integrins: Biological and clinical relevance
70. CD14 and other recognition molecules for lipopolysaccharide: A review
71. My-1, new myeloid-specific antigen identified by a mouse monoclonal antibody
72. Assessment of aldehyde dehydrogenase in viable cells